Andrew M. Rauth

Publications

• Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia
  Cancer Research. Nov, 2016  |   Pubmed ID: 27758881
• Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-encapsulated Doxorubicin-mitomycin C and Enable Their Spatiotemporal Co-delivery and Local Bioavailability in Breast Tumor
  Nanomedicine : Nanotechnology, Biology, and Medicine. Jul, 2016  |   Pubmed ID: 26772427
• Optimization of Controlled Release Nanoparticle Formulation of Verapamil Hydrochloride Using Artificial Neural Networks with Genetic Algorithm and Response Surface Methodology
  European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Aug, 2015  |   Pubmed ID: 25986587
• Manganese Oxide and Docetaxel Co-loaded Fluorescent Polymer Nanoparticles for Dual Modal Imaging and Chemotherapy of Breast Cancer
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Jul, 2015  |   Pubmed ID: 25908171
• Optimizing the Design and in Vitro Evaluation of Bioreactive Glucose Oxidase-microspheres for Enhanced Cytotoxicity Against Multidrug Resistant Breast Cancer Cells
  Colloids and Surfaces. B, Biointerfaces. Jun, 2015  |   Pubmed ID: 25896537
• Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
  Molecular Pharmaceutics. Aug, 2014  |   Pubmed ID: 24830351
• Matrigel Alters the Pathophysiology of Orthotopic Human Breast Adenocarcinoma Xenografts with Implications for Nanomedicine Evaluation
  Nanomedicine : Nanotechnology, Biology, and Medicine. Aug, 2013  |   Pubmed ID: 23434679
• Multifunctional Terpolymeric MRI Contrast Agent with Superior Signal Enhancement in Blood and Tumor
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Apr, 2013  |   Pubmed ID: 23353806
• Doxorubicin and Mitomycin C Co-loaded Polymer-lipid Hybrid Nanoparticles Inhibit Growth of Sensitive and Multidrug Resistant Human Mammary Tumor Xenografts
  Cancer Letters. Jul, 2013  |   Pubmed ID: 22902994
• Evaluation of New Bi-functional Terpolymeric Nanoparticles for Simultaneous in Vivo Optical Imaging and Chemotherapy of Breast Cancer
  Drug Delivery and Translational Research. Dec, 2012  |   Pubmed ID: 25787324
• A Novel Nanoparticle Formulation Overcomes Multiple Types of Membrane Efflux Pumps in Human Breast Cancer Cells
  Drug Delivery and Translational Research. Apr, 2012  |   Pubmed ID: 25786718
• A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor α(v) β(3) Integrin Receptors Reveals Cyclic RGD As a Double-edged Sword
  Advanced Healthcare Materials. Sep, 2012  |   Pubmed ID: 23184795
• 熱がトリガー '消灯-点灯-消灯' 応答ガドリニウム ハイドロゲル脂質ナノ粒子の非侵襲的磁気共鳴画像温度計測のためのカスタマイズ可能な温度ウィンドウを定義します。
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Feb, 2012  |   Pubmed ID: 21939700
• A Novel Doxorubicin-mitomycin C Co-encapsulated Nanoparticle Formulation Exhibits Anti-cancer Synergy in Multidrug Resistant Human Breast Cancer Cells
  Breast Cancer Research and Treatment. Jan, 2010  |   Pubmed ID: 19221875
• Molecular Interactions, Internal Structure and Drug Release Kinetics of Rationally Developed Polymer-lipid Hybrid Nanoparticles
  Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2008  |   Pubmed ID: 18406489
• On the Synergistic Effect of Doxorubicin and Mitomycin C Against Breast Cancer Cells
  Drug Metabolism and Drug Interactions. 2007  |   Pubmed ID: 18447000
• Chemotherapy with Anticancer Drugs Encapsulated in Solid Lipid Nanoparticles
  Advanced Drug Delivery Reviews. Jul, 2007  |   Pubmed ID: 17532091
• Screening of Lipid Carriers and Characterization of Drug-polymer-lipid Interactions for the Rational Design of Polymer-lipid Hybrid Nanoparticles (PLN)
  Pharmaceutical Research. Aug, 2006  |   Pubmed ID: 16850265
• A New Polymer-lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-resistant Human Breast Cancer Cells
  Pharmaceutical Research. Jul, 2006  |   Pubmed ID: 16786442
• A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-lipid Hybrid Nanoparticle System
  The Journal of Pharmacology and Experimental Therapeutics. Jun, 2006  |   Pubmed ID: 16547167
• In Vitro Toxicity to Breast Cancer Cells of Microsphere-delivered Mitomycin C and Its Combination with Doxorubicin
  European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Apr, 2006  |   Pubmed ID: 16330194
• Biodegradable Dextran-based Microspheres for Delivery of Anticancer Drug Mitomycin C
  Biomaterials. Sep, 2005  |   Pubmed ID: 15814136
• Prediction of Kinetics of Doxorubicin Release from Sulfopropyl Dextran Ion-exchange Microspheres Using Artificial Neural Networks
  European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. Apr, 2005  |   Pubmed ID: 15784330
• In Vivo Efficacy and Toxicity of Intratumorally Delivered Mitomycin C and Its Combination with Doxorubicin Using Microsphere Formulations
  Anti-cancer Drugs. Apr, 2005  |   Pubmed ID: 15746579
• A New Approach to the in Vivo and in Vitro Investigation of Drug Release from Locoregionally Delivered Microspheres
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2004  |   Pubmed ID: 15491816
• Delivery of an Anticancer Drug and a Chemosensitizer to Murine Breast Sarcoma by Intratumoral Injection of Sulfopropyl Dextran Microspheres
  The Journal of Pharmacy and Pharmacology. Aug, 2003  |   Pubmed ID: 12956895